CD27 showed significantly high expression in 21 cancers, the high expression and good prognosis of CD27 in these cancers prove the theory that CD27 acts as a co-stimulatory immune checkpoint in tumor cell immunity. This evidence concerns the gene CD27 and neoplasm.